December 30, 2025

McDermott advises H.I.G. Capital on cross-border sale of Xtera

December 30, 2025

McDermott advises Main Capital on CarWise's acquisition of Carano

December 26, 2025

McDermott Will & Schulte advises ContextLogic Holdings, Inc. in connection with its $907.5 million acquisition of US Salt

December 23, 2025

McDermott Will & Schulte advises Amwins Group Inc. on strategic joint venture expected to support $400m of premium target

December 23, 2025

McDermott Advises Main Capital Partners on the Acquisition of German Logistics Software Provider EIKONA

December 22, 2025

McDermott Will & Schulte wins summary judgment for Bitcoin miner Block Mining in first major Bitcoin-halving decision

December 22, 2025

McDermott Will & Schulte secures dismissal of federal indictment for former senior US government official

December 22, 2025

McDermott Will & Schulte advises Qualium Investissement on its First Continuation Fund Structuring

December 22, 2025

McDermott successfully acted for Tecnimont S.p.A. and MT Russia LLC in the Court of Appeal, upholding an English High Court Order to enforce an arbitral tribunal’s peremptory anti-suit orders

December 19, 2025

McDermott Will & Schulte climbs to Number 10 in Lexology Data 100: Global Elite

December 19, 2025

McDermott Will & Schulte advises the founders of Hueber Assurances Group on their first LBO

December 18, 2025

McDermott Will & Schulte advises Theresia Gouw on acquisition of Major League Volleyball expansion franchise

December 18, 2025

McDermott Will & Schulte advises Monumental Sports & Entertainment in its minority investments by Arctos Partners and the Qatar Investment Authority

December 18, 2025

McDermott Will & Schulte represents Mills family in Medline’s $6.26 billion IPO, largest IPO of 2025

December 18, 2025

McDermott Advises on Financing the Launch of New Tax and Audit Platform Atania

December 16, 2025

McDermott Will & Schulte advises Kingswood Capital Management in definitive agreement to acquire Quipt Home Medical

December 15, 2025

McDermott Will & Schulte advises Sobi in $1.5 billion cross-border, biotech acquisition to advance gout treatments

December 12, 2025

McDermott Will & Schulte advises Obra Capital as an equity sponsor for an insurance financing solution